Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Patrick Kelly, MD
Forma Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars Sinai
Los Angeles, California, United States
- Florida Cancer Specialists
Sarasota, Florida, United States
- Moffitt Cancer Center
Tampa, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Maryland, Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, United States
- Levine Cancer Institute
Charlotte, North Carolina, United States
- Sarah Cannon Research Institute
Nashville, Tennessee, United States
- Md Anderson Cancer Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2015
- Primary completion
- 31 Mar 2019
- Completion
- 31 Mar 2019
- Last update posted
- 21 Nov 2023
- Registered enrollment
- 94
- Registry id
- NCT02543879
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.